Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer

Fig. 3

Combination therapy of anti-CD25 and anti-TGF-β enhances intra-tumor immune response. a CD8 expression in tumor tissues under different therapies. Flow cytometry data showing the percentage of CD4+ or CD8+ T cells among all CD3+ T cells in b spleen and c blood. d IHC data showing the amounts of CD8+ T cells in immunohistochemistry staining. The Elisa data showing the concentration of e TGF-β, f IL-10, and g IIFN-γ within tumor tissues. *< 0.05, **< 0.001, ****< 0.0001

Back to article page